Weekly subcutaneous (s.c.)administration of 6 mg/kg drisapersen for 72 weeks was associated with a slight but statistically significant increase in the concentration of both total protein and alpha-1-microglobulin (A1M) in the urine of DMD patients (Figures 1A and 1D). Here, AMBP is linked to Duchenne muscular dystrophy.